Manifold Bio
Naveen Mehta serves as the Senior Director of Drug Discovery and Early Development at Manifold Bio since July 2023, leading programs focused on oncology and neurodegenerative disease. Prior experience includes a role as Director of Preclinical R&D at Cullinan Oncology, where Naveen led the development of an intratumoral collagen-binding IL2/IL12 fusion protein and managed biologics programs. Naveen's academic journey includes a PhD from the Massachusetts Institute of Technology, focusing on T cell vaccine responses, and a Bachelor of Science in Biomedical/Medical Engineering from The University of Texas at Austin. Additional experiences include roles at Vida Ventures, Neon Therapeutics, and the University of Texas at Austin, contributing to various research and development efforts in immunotherapy and drug development.
This person is not in any teams
This person is not in any offices
Manifold Bio
2 followers
Manifold Bio's mission is to build technology that exponentially increases measurement throughput at all stages of drug development.